Your browser doesn't support javascript.
loading
Viagra Enables Efficient, Single-Day Hematopoietic Stem Cell Mobilization.
Smith-Berdan, Stephanie; Bercasio, Alyssa; Rajendiran, Smrithi; Forsberg, E Camilla.
Afiliação
  • Smith-Berdan S; Institute for the Biology of Stem Cells, Department of Biomolecular Engineering, University of California, 1156 High Street, Santa Cruz, CA 95064, USA.
  • Bercasio A; Institute for the Biology of Stem Cells, Department of Biomolecular Engineering, University of California, 1156 High Street, Santa Cruz, CA 95064, USA.
  • Rajendiran S; Institute for the Biology of Stem Cells, Department of Biomolecular Engineering, University of California, 1156 High Street, Santa Cruz, CA 95064, USA.
  • Forsberg EC; Institute for the Biology of Stem Cells, Department of Biomolecular Engineering, University of California, 1156 High Street, Santa Cruz, CA 95064, USA. Electronic address: cforsber@ucsc.edu.
Stem Cell Reports ; 13(5): 787-792, 2019 11 12.
Article em En | MEDLINE | ID: mdl-31607567
Hematopoietic stem cell (HSC) transplantation is a curative treatment for a variety of blood and immune disorders. Currently available methods to obtain donor HSCs are suboptimal, and the limited supply of donor HSCs hampers the success and availability of HSC transplantation therapies. We recently showed that manipulation of vascular integrity can be employed to induce HSC mobilization from the bone marrow to the blood stream, facilitating non-invasive collection of HSCs. Here, we tested whether FDA-approved vasodilators are capable of mobilizing HSCs. We found that a rapid, 2-h regimen of a single oral dose of Viagra (sildenafil citrate) combined with a single injection of the CXCR4 antagonist AMD3100 leads to efficient HSC mobilization at levels rivaling the standard-of-care 5-day regimen of granulocyte-colony stimulating factor (G-CSF/Filgrastim/Neupogen). Our findings solidify vascular integrity as an essential regulator of HSC trafficking and provide an attractive, single-day regimen for HSC mobilization using already FDA-approved drugs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasodilatadores / Mobilização de Células-Tronco Hematopoéticas / Citrato de Sildenafila Limite: Animals / Female / Humans / Male Idioma: En Revista: Stem Cell Reports Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasodilatadores / Mobilização de Células-Tronco Hematopoéticas / Citrato de Sildenafila Limite: Animals / Female / Humans / Male Idioma: En Revista: Stem Cell Reports Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos